Implantable cardioverter-defibrillators (ICDs) are generally reliable medical devices that
have the potential to add quality years of life for appropriate candidates. Indications for ICDs …

The implantable cardioverter defibrillator (ICD) has emerged as an important treatment
option for selected patients who are at risk of sudden cardiac death. Randomized trials have …

Background: Although implantable cardioverter‐defibrillators (ICDs) reduce mortality in
selected patients, they are also associated with potential risks. Periprocedural decision …

Despite the demonstrated efficacy of implantable cardioverter defibrillators (ICDs) in
reducing sudden and total mortality in selected patients, their implantation rates vary greatly …

Aims Recent guidelines have recommended more wide-ranging indications for the use of
implantable cardioverter defibrillator (ICD) therapy, yet even more restrained previous …

Benefits of the Implantable Cardioverter-Defibrillator Andrew E. Epstein The state-of-the-art
review by Tung and colleagues provides a thoughtful perspective on balancing the benefits …

The implantable cardioverter defibrillator (ICD) is a costly new treatment for patients at high
risk of sudden cardiac death. Randomized trials of the ICD showed it to be effective in some …

BACKGROUND: There are scarce population-based data on the use, complication rates,
and outcomes of patients receiving implantable cardioverter defibrillators (ICDs) …

In a systematic review1 of 12 randomized controlled trials (RCTs) accounting for a total of
8516 patients with left ventricular (LV) systolic dysfunction (regardless of whether the …

■ Die endgültige Entscheidung zur Implantation eines ICD sollte auf der Basis
evidenzbasierter Medizin unter Berücksichtigung des individuellen Patientenprofils erfolgen …